1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. CARGO THERAPEUTICS INC
CARGO Therapeutics Inc XNAS: CRGX

Watchlist

Portfolio

Alert


Insider Trading disclosures for CARGO Therapeutics Inc

The latest disclosure was made by Jane Pritchett Henderson in CARGO Therapeutics Inc where a trade of 25,000 Stock Option (Right to Buy) done was reported to US exchanges on Aug. 19, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Jane Pritchett Henderson Director Sale or transfer of securities back to the company at price $ 0.00 per share. 19 Aug 2025 25,000 0 - - Stock Option (Right to Buy)
Kapil Dhingra Director Sale or transfer of securities back to the company at price $ 0.00 per share. 19 Aug 2025 25,000 0 - - Stock Option (Right to Buy)
John A. Orwin Director Sale or transfer of securities back to the company at price $ 0.00 per share. 19 Aug 2025 15,865 0 - - Stock Option (Right to Buy)
Krishnan Viswanadhan Director Sale or transfer of securities back to the company at price $ 0.00 per share. 19 Aug 2025 25,000 0 - - Stock Option (Right to Buy)
Krishnan Viswanadhan Director Sale or transfer of securities back to the company at price $ 0.00 per share. 19 Aug 2025 3,173 0 - - Stock Option (Right to Buy)
Abraham Bassan Director Sale or transfer of securities back to the company at price $ 0.00 per share. 19 Aug 2025 25,000 0 - - Stock Option (Right to Buy)
Reid M. Huber Director Sale or transfer of securities back to the company at price $ 0.00 per share. 19 Aug 2025 25,000 0 - - Stock Option (Right to Buy)
David Charles Lubner Director Sale or transfer of securities back to the company at price $ 0.00 per share. 19 Aug 2025 25,000 0 - - Stock Option (Right to Buy)
John A. Orwin Director Sale or transfer of securities back to the company at price $ 0.00 per share. 19 Aug 2025 25,000 0 - - Stock Option (Right to Buy)
Anup Radhakrishnan See Remarks 18 Aug 2025 57,345 63,436 - 4.4 251,114 Common Stock
Anup Radhakrishnan See Remarks Sale or transfer of securities back to the company at price $ 0.00 per share. 18 Aug 2025 14,679 0 - - Stock Option (Right to Buy)
Anup Radhakrishnan See Remarks Sale or transfer of securities back to the company at price $ 4.38 per share. 18 Aug 2025 63,436 0 - 4.4 277,786 Common Stock
Anup Radhakrishnan See Remarks Sale of securities on an exchange or to another person at price $ 4.18 per share. 02 Jul 2025 1,632 120,781 - 4.2 6,822 Common Stock
Krishnan Viswanadhan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 25,000 25,000 - - Stock Option (Right to Buy)
Abraham Bassan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 25,000 25,000 - - Stock Option (Right to Buy)
Reid M. Huber Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 25,000 25,000 - - Stock Option (Right to Buy)
David Charles Lubner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 25,000 25,000 - - Stock Option (Right to Buy)
John A. Orwin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 25,000 25,000 - - Stock Option (Right to Buy)
Kapil Dhingra Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 25,000 25,000 - - Stock Option (Right to Buy)
Jane Pritchett Henderson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 25,000 25,000 - - Stock Option (Right to Buy)
Anup Radhakrishnan See Remarks Sale of securities on an exchange or to another person at price $ 3.84 per share. 14 May 2025 27,404 122,413 - 3.8 105,272 Common Stock
Anup Radhakrishnan See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2025 72,500 149,817 - 0 Common Stock
Anup Radhakrishnan See Remarks Sale of securities on an exchange or to another person at price $ 4.00 per share. 03 Apr 2025 1,629 77,317 - 4.0 6,522 Common Stock
Anup Radhakrishnan See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Mar 2025 72,500 78,946 - 0 Common Stock
Shishir Gadam Chief Technical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Mar 2025 60,000 89,480 - 0 Common Stock
Gina Chapman Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Mar 2025 200,000 303,905 - 0 Common Stock
Ginna G. Laport Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Mar 2025 50,000 50,000 - 0 Common Stock
Anup Radhakrishnan See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Nov 2024 40,000 40,000 - - Stock Option (Right to Buy)
Gina Chapman Director, President & CEO 18 Sep 2024 7,166 111,071 - 5.0 36,045 Common Stock
Gina Chapman Director, President & CEO 18 Sep 2024 2,975 549,515 - - Stock Option (Right to Buy)
Gina Chapman Director, President & CEO 18 Sep 2024 7,166 552,490 - - Stock Option (Right to Buy)
Gina Chapman Director, President & CEO 18 Sep 2024 2,975 103,905 - 25.0 74,457 Common Stock
Gina Chapman Director, President & CEO 18 Sep 2024 2,975 106,880 - 5.0 14,964 Common Stock
Anup Radhakrishnan Chief Financial Officer Sale of securities on an exchange or to another person at price $ 25.28 per share. 18 Sep 2024 1,600 6,446 - 25.3 40,452 Common Stock
Anup Radhakrishnan Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Sep 2024 1,600 53,180 - - Stock Option (Right to Buy)
Anup Radhakrishnan Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.03 per share. 18 Sep 2024 1,600 8,046 - 5.0 8,048 Common Stock
Gina Chapman Director, President & CEO 18 Sep 2024 7,166 103,905 - 25.1 179,775 Common Stock
David Charles Lubner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 23,742 23,742 - - Stock Option (Right to Buy)
Jane Pritchett Henderson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 39,402 39,402 - - Stock Option (Right to Buy)
Jane Pritchett Henderson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 19,785 19,785 - - Stock Option (Right to Buy)
Kapil Dhingra Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 11,871 11,871 - - Stock Option (Right to Buy)
John A. Orwin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 23,742 23,742 - - Stock Option (Right to Buy)
Reid M. Huber Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 23,742 23,742 - - Stock Option (Right to Buy)
Abraham Bassan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 23,742 23,742 - - Stock Option (Right to Buy)
Krishnan Viswanadhan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 23,742 23,742 - - Stock Option (Right to Buy)
Kapil Dhingra Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Apr 2024 49,265 49,265 - - Stock Option (Right to Buy)
Ginna G. Laport Chief Medical Officer 01 Mar 2024 100,000 100,000 - - Stock Option (Right to Buy)
Shishir Gadam Chief Technical Officer 01 Mar 2024 100,000 100,000 - - Stock Option (Right to Buy)
Anup Radhakrishnan Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 130,000 130,000 - - Stock Option (Right to Buy)
Gina Chapman Director, President & CEO 01 Mar 2024 400,000 400,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters